Kotak替代资产管理人为其新的生命科学基金(针对新开办的医疗保健机构)担保250卢比。 Kotak Alternate Asset Managers secures Rs 250 crore for its new life sciences fund, targeting healthcare startups.

Kotak 替代资产管理人有限公司是Kotak Mahindra集团的一部分,已经实现了生命科学基金的首个关闭,筹集了250卢比,总金额达到1 600卢比。 Kotak Alternate Asset Managers Ltd., part of Kotak Mahindra Group, has achieved the first close of its life sciences fund with Rs 250 crore raised, aiming for a total of Rs 1,600 crore. 该基金的对象是药品、生物技术、医疗设备和数字保健等保健部门的早期增长阶段公司。 The fund targets early- to growth-stage companies in healthcare sectors like pharmaceuticals, biotech, medical devices, and digital health. Kotak公司先前投资20多家生命科学公司,管理费用约为220亿美元。 Kotak has previously invested in over 20 life sciences companies with around $22 billion under management.